These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24270235)

  • 21. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis.
    Pages ON; Aubert S; Combes A; Luyt CE; Pavie A; Léger P; Gandjbakhch I; Leprince P
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):194-7. PubMed ID: 19154925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bridge to recovery with ventricular assist device support for eosinophilic myocarditis].
    Suematsu Y; Morizumi S; Okamura K; Gon S; Shimizu T; Kawata M
    Kyobu Geka; 2014 Jul; 67(7):587-91. PubMed ID: 25137336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A minimally invasive off-pump implantation technique for continuous-flow left ventricular assist devices: early experience.
    Strueber M; Meyer AL; Feussner M; Ender J; Correia JC; Mohr FW
    J Heart Lung Transplant; 2014 Aug; 33(8):851-6. PubMed ID: 25063531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reflections on external circulatory assistance. Apropos of 8 patients treated with the MEDOS system].
    Villemot JP; Carteaux JP; Bischoff N; Mertes PM; Longrois D; Hubert T; Mattei MF; Lecompte T
    Chirurgie; 1997 Jan; 121(9-10):690-5. PubMed ID: 9138333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular arrhythmias following continuous-flow left ventricular assist device implantation: A systematic review.
    Gordon JS; Maynes EJ; Choi JH; Wood CT; Weber MP; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2020 Aug; 44(8):E313-E325. PubMed ID: 32043582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.
    Bashir J; Legare JF; Freed DH; Cheung A; Rao V; Toma M
    Can J Cardiol; 2014 Dec; 30(12):1662-7. PubMed ID: 25475468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular tachycardia and preload deficiency post LVAD - The importance of integrated assessment.
    Bohonos CJ; Bechtum EL; Luckhardt AJ; Clavell AL; Stulak JM; Boilson BA
    Heart Lung; 2020; 49(5):481-487. PubMed ID: 32334843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful left ventricular assist device re-implantation with omental covering for MDRP device infection.
    Inafuku H; Kuniyoshi Y; Yamashiro S; Totsuka Y; Ono M
    J Artif Organs; 2016 Jun; 19(2):192-5. PubMed ID: 26740211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impella LP 5.0 as a bridge to long-term circulatory support.
    Samoukovic G; Rosu C; Giannetti N; Cecere R
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):682-3. PubMed ID: 19254945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of extended myocardial infarction treated with the left ventricular assist device (LVAD) before and after the operation--the value and limitation of LVAD].
    Akamatsu H; Sakakibara T; Mishima M; Kodama K; Matsuwaka R; Matsuda H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Oct; 38(10):2122-7. PubMed ID: 2266288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis.
    Coffin ST; Haglund NA; Davis ME; Xu M; Dunlay SM; Cowger JA; Shah P; Aaronson KD; Pagani FD; Stulak JM; Maltais S;
    J Heart Lung Transplant; 2015 Dec; 34(12):1578-85. PubMed ID: 26522376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.
    Andrade JG; Al-Saloos H; Jeewa A; Sandor GG; Cheung A
    J Heart Lung Transplant; 2010 Jan; 29(1):96-7. PubMed ID: 19782584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
    Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
    Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridge-to-recovery from acute myocarditis in a 12-year-old child.
    Hotz H; Linneweber J; Dohmen PM; Vargas O; Braun J; Konertz W
    Artif Organs; 2004 Jun; 28(6):587-9. PubMed ID: 15153152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device].
    Wilde J; Klingel K; Kandolf R; Schuler G; Sandri M
    Dtsch Med Wochenschr; 2013 Mar; 138(12):576-80. PubMed ID: 23483417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new percutan assist device for treatment of fulminant myocarditis].
    Lindholm MG; Engstrøm T; Boesgaard S; Hassager C
    Ugeskr Laeger; 2007 Sep; 169(39):3303-4. PubMed ID: 17953892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.